Guides Early Treatment Selections

• Most useful in choosing a patient's first and second treatment regimens before the buildup of complex mutation patterns.
• Supplements phenotypic information in later lines of therapy as resistance increases.

Leading-Edge Test Technology

• Uses vectors derived from patient virus to provide highest degree of accuracy in identifying drug resistance mutations.
• Detects mixtures of wild-type and drug-resistant viruses as low as 10% of total viral population.
• Sensitive enough to be performed on patient samples with viral loads as low as 500 copies/mL.

Trusted Interpretation

• Test results powered by the world's largest database of HIV genotype-phenotype matches – enables continual refinement of interpretation and strengthens its association with treatment outcomes.
• Interpretation algorithm relied on by academic investigators and leading pharmaceutical companies for clinical research and new drug development.
• Superior predictor of virologic response to protease inhibitors in multiple comparative analyses ^1,2